An Act limiting excessive growth in the operating budgets of health care oversight agencies
Senate: Accompanied a study order, see S2931
Email me when S 864 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track S 864. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill adds a new subsection to two Massachusetts statutes that caps the yearly rise in assessed amounts for acute hospitals, ambulatory surgical centers, non‑hospital provider organizations, pharmaceutical manufacturers, pharmacy benefit managers, and surcharge payors. The cap is tied to a health‑care cost growth benchmark approved by the relevant commission. It aims to prevent fee growth from outpacing overall health‑care cost trends.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about S 864
3 free questions a day, no accountHearings
- Health Care Resources & Market Oversight; Pharmaceutical Access, Cost & TransparencyJoint Committee on Health Care Financing · Jun 2, 2025
History
- Accompanied a study order, see S2931
- Hearing scheduled for 06/02/2025 from 11:00 AM-03:00 PM in Gardner Auditorium
- Referred to the committee on Health Care Financing
- House concurred
Sponsors
- Barry R. Finegold · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when S 864 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track S 864 freeOr ask your AI assistant about S 864 directly:
Add to Claude, ChatGPT or Cursor